The University of Chicago Header Logo

Connection

Kenneth S. Cohen to Cetuximab

Back to Details
This is a "connection" page, showing publications Kenneth S. Cohen has written about Cetuximab.
Kenneth S. Cohen
Connection Strength
0.035
Cetuximab
  1. A pediatric trial of radiation/cetuximab followed by irinotecan/cetuximab in newly diagnosed diffuse pontine gliomas and high-grade astrocytomas: A Pediatric Oncology Experimental Therapeutics Investigators' Consortium study. Pediatr Blood Cancer. 2017 Nov; 64(11).
    View in: PubMed
    Score: 0.035
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.